Skip to main content

Table 4 Regional end-expiratory pleural and transpulmonary pressures

From: Comparative effects of flow vs. volume-controlled one-lung ventilation on gas exchange and respiratory system mechanics in pigs

Parameter

Therapy

ANOVA (P=)

Group

Mode

20′

40′

60′

Seq

Group

Mode

Time

Mixed

PPvent (cmH2O)

    

0.073

0.994

0.022

0.437

0.116

 Norm

VCV

0.1 ± 2.6

− 0.1 ± 2.7

− 0.0 ± 3.2

  

0.076

0.866

0.256

FCV

− 1.3 ± 3.6

− 1.0 ± 3.4

− 0.2 ± 3.5

     

 Hypo

VCV

0.3 ± 0.7

− 0.6 ± 2.4

− 0.3 ± 2.9

  

0.161

0.327

0.288

FCV

− 0.7 ± 2.1

− 0.9 ± 3.0

− 0.3 ± 1.7

     

PPdors (cmH2O)

    

0.054

0.079

0.975

0.045

0.744

 Norm

VCV

− 1.9 ± 3.1

− 1.5 ± 4.1

0.1 ± 3.0

     

FCV

− 1.0 ± 3.1

− 1.6 ± 3.7

− 0.8 ± 2.9

     

 Hypo

VCV

0.9 ± 0.7

0.6 ± 1.5

1.1 ± 0.8

     

FCV

− 0.3 ± 3.2

0.6 ± 0.9

1.1 ± 0.8

     

PPcaud (cmH2O)

    

0.754

0.109

0.211

0.202

0.447

 Norm

VCV

− 0.2 ± 3.2

− 0.7 ± 3.5

0.1 ± 3.3

     

FCV

− 1.8 ± 4

− 0.8 ± 3.4

− 0.0 ± 3.4

     

 Hypo

VCV

1.0 ± 2.0

1.9 ± 1.4

1.7 ± 1.3

     

FCV

1.3 ± 1.6

1.5 ± 1.4

1.5 ± 1.6

     

TPvent (cmH2O)

    

0.103

0.970

0.262

0.461

0.076

 Norm

VCV

5.4 ± 2.5

5.6 ± 2.8

5.4 ± 3.1

     

FCV

5.8 ± 3.5

5.3 ± 3.2

4.5 ± 3.2

     

 Hypo

VCV

5.11 ± 0.7

6 ± 2.4

5.7 ± 2.8

     

FCV

5.22 ± 2.2

5.4 ± 3.0

4.8 ± 1.6

     

TPdors (cmH2O)

    

0.092

0.098

0.347

0.036

0.984

 Norm

VCV

7.3 ± 3.0

7.0 ± 4.4

5.3 ± 2.8

     

FCV

5.8 ± 3.5

5.5 ± 3.2

5 ± 2.7

     

 Hypo

VCV

4.5 ± 0.6

4.8 ± 1.6

4.3 ± 0.8

     

FCV

4.9 ± 2.8

3.9 ± 0.8

3.36 ± 1.3

     

TPcaud (cmH2O)

    

0.626

0.060

0.839

0.311

0.953

 Norm

VCV

5.8 ± 3.0

6.1 ± 3.6

5.3 ± 3.2

     

FCV

6.6 ± 4.4

6.0 ± 3.9

5.6 ± 4.4

     

 Hypo

VCV

4.4 ± 1.9

3.5 ± 1.3

3.7 ± 1.2

     

FCV

3.2 ± 1.8

3.0 ± 1.6

3.0 ± 2.0

     
  1. Values in mean ± standard deviation; Statistical P values according to linear mixed-effects repeated measures ANOVA with within subject factors: mode of ventilation (volume or flow-controlled ventilation) and time of therapy in minutes; and between subject factors group of therapy (normovolaemia or hypovolaemia) and randomization sequence (volume or flow-controlled ventilation first). Significance was accepted for P < 0.05. Statistical analysis was performed in R statistical programming language and the package lme4
  2. FCV flow-controlled ventilation, VCV volume-controlled ventilation, PIPvent end-expiratory ventral pleural pressure, PIPdors end-expiratory dorsal pleural pressure, PIPcaud end-expiratory caudal pleural pressure, TPvent end-expiratory ventral transpulmonary pressure, TPdors end-expiratory dorsal transpulmonary pressure, TPcaud end-expiratory caudal transpulmonary pressure